© 2005 Foundation for Promotion of Cancer Research
Primary Carcinoma of the Female Urethra: Single Center Experience of 18 Cases
Department of Genito-urinary and Gynecology Oncology, Tata Memorial Hospital, Mumbai, India
For reprints and all correspondence: Yuvaraja B. Thyavihally, Assistant Professor, Department of Genito-urinary and Gynecology Oncology, Tata Memorial Hospital, Parel, Mumbai 400 012, India. E-mail: tbyraja{at}rediffmail.com
Received October 5, 2004; accepted December 4, 2004
Background: Primary carcinoma of the urethra is more common in women than in men. Vague symptoms in the early stages delay the diagnosis in most patients. Surgery and radiotherapy are used as treatment modalities for these tumors, either alone or in combination.
Methods: We retrospectively analyzed the records of 18 female patients with urethral cancer presented to our institution. Secondary tumors involving the urethra from adjacent organs like bladder carcinoma and gynecological cancer were excluded.
Results: In our review, the overall survival was 74% at 3 years and 33% at 5 years with median overall survival of 51 months. There was a statistically better overall survival in patients with early stage tumors compared with later stage disease (P = 0.03) and patients with distally located tumors had better survival compared with proximal and whole urethral involvement.
Conclusions: The prognosis is poor in advanced stages and in those with proximal or whole urethral involvement, requiring extensive surgical procedures. The aim of treatment in distal urethral carcinomas should be local excision and radiotherapy, thereby preserving the bladder.
Key Words: carcinoma • radiotherapy • surgery • urethra